The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma

BACKGROUND. Vascular endothelial growth factor pathway (VEGF)-tyrosine kinase inhibitors (TKIs) are used as the first-line treatment for patients with metastatic clear cell renal cell carcinoma (mCCRCC). Recently, programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) blockade emerged as pr...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Oncologist
मुख्य लेखकों: Shin, Su-Jin, Jeon, Yoon Kyung, Cho, Yong Mee, Lee, Jae-Lyun, Chung, Doo Hyun, Park, Ji Young, Go, Heounjeong
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: AlphaMed Press 2015
विषय:
Genitourinary Cancer
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4718425/
https://ncbi.nlm.nih.gov/pubmed/26424759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0151
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन